Reunion, FLNCT07277270Now EnrollingIRB Ready

Neoplasms Clinical Trial in Reunion, FL

Access cutting-edge neoplasms treatment through this phase 1 clinical trial at a research site in Reunion. Study-provided care at no cost to qualified participants.

Sponsored by GlaxoSmithKline

Quick Self-Assessment

See if you qualify for this Reunion location

Preparing your pre-screening questions…

Expert Care in Reunion

Access neoplasms specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neoplasms treatment provided free

Apply for This Reunion Location

Check if you qualify for this neoplasms clinical trial in Reunion, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Reunion

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Reunion site if eligible
  4. 4Begin participation

About This Neoplasms Study in Reunion

The goal of this clinical trial is to test a new medicine called GSK5764227, which delivers a toxin directly to cancer cells to destroy them while sparing healthy cells. The study will combine GSK5764227 with standard treatments to evaluate its safety, examine how the body processes it, check if it triggers any immune responses, and assess whether it can shrink or control cancer.

Sponsor: GlaxoSmithKline

Who Can Participate

Inclusion Criteria

Has an ECOG performance status of 0 or 1, with no deterioration in the 2 weeks before first dose.
Has adequate organ function.
Has histologically confirmed unresectable adenocarcinoma or unresectable metastatic adenocarcinoma of the colon or rectum. (Cohort A)
Histologically or cytologically confirmed adenocarcinoma of the prostate (Cohort B)

Exclusion Criteria

Has a malignancy (except disease under study) that has progressed or required active treatment within the past 24 months except for basal cell or squamous cell carcinomas of the skin or in-situ carcinomas \[e.g., breast, cervix, bladder\] that have been resected with no evidence of disease.
Has had any major surgery within 28 days prior to first dose.
Has clinically significant bleeding symptoms or significant bleeding tendency within 1 month prior to the first dose.
Has serious infection within 4 weeks prior to the first dose,
Has untreated brain or central nervous system (CNS) metastases or brain/CNS metastases that have progressed
Any evidence of current interstitial lung disease (ILD) or pneumonitis OR a prior history of ILD requiring high-dose glucocorticoids or non-infectious pneumonitis requiring high-dose glucocorticoids.
Has a history of autoimmune disease that has required systemic treatments in the 2 years prior to screening.
Has received immunosuppressive agents within 30 days prior to first dose of study intervention (or requires long-term \[30 days or longer\]). Low-dose corticosteroids (prednisone ≤10 milligrams (mg)/day or equivalent) may be administered.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Reunion?

Yes, this clinical trial (NCT07277270) has an active research site in Reunion, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neoplasms Treatment Options in Reunion, FL

If you're searching for neoplasms treatment options in Reunion, FL, this clinical trial (NCT07277270) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Reunion research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced neoplasms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neoplasms clinical trials near you to find additional studies recruiting in your area.

More Myeloproliferative Neoplasms Trials in Reunion, FL

See all myeloproliferative neoplasms clinical trials recruiting in Reunion — not just this study.

Browse Myeloproliferative Neoplasms Trials in Reunion →

Browse More Trials by Condition

Myeloproliferative Neoplasms TrialsMultiple Sclerosis TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Reunion?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Reunion, FL